{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:38:00Z","timestamp":1790746680270,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12933-017-0509-7","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T07:24:52Z","timestamp":1487143492000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients"],"prefix":"10.1186","volume":"16","author":[{"given":"Aur\u00e9lien","family":"Mary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Hartemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Liabeuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole Elodie","family":"Aubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Kemel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe Elie","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Cluzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Lenglet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad A.","family":"Massy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Daniel","family":"Lalau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romuald","family":"Mentaverri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bourron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa\u00efd","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,15]]},"reference":[{"key":"509_CR1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/VHRM.S4822","volume":"5","author":"RJMW Rennenberg","year":"2009","unstructured":"Rennenberg RJMW, Kessels AGH, Schurgers LJ, van Engelshoven JMA, de Leeuw PW, Kroon AA. Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis. Vasc Health Risk Manag. 2009;5:185\u201397.","journal-title":"Vasc Health Risk Manag."},{"key":"509_CR2","doi-asserted-by":"crossref","first-page":"972","DOI":"10.2337\/dc12-1548","volume":"36","author":"S Agarwal","year":"2013","unstructured":"Agarwal S, Cox AJ, Herrington DM, Jorgensen NW, Xu J, Freedman BI, et al. Coronary calcium score predicts cardiovascular mortality in diabetes: diabetes heart study. Diabetes Care. 2013;36:972\u20137.","journal-title":"Diabetes Care"},{"key":"509_CR3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jcmg.2012.02.006","volume":"5","author":"JC Kovacic","year":"2012","unstructured":"Kovacic JC, Fuster V. Vascular calcification, diabetes and cardiovascular disease\u2014connecting the dots. JACC Cardiovasc Imag. 2012;5:367\u20139.","journal-title":"JACC Cardiovasc Imag."},{"key":"509_CR4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11892-003-0049-2","volume":"3","author":"NX Chen","year":"2003","unstructured":"Chen NX, Moe SM. Arterial calcification in diabetes. Curr Diabetes Rep. 2003;3:28\u201332.","journal-title":"Curr Diabetes Rep"},{"key":"509_CR5","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1136\/bmj.284.6320.928","volume":"284","author":"ME Edmonds","year":"1982","unstructured":"Edmonds ME, Morrison N, Laws JW, Watkins PJ. Medial arterial calcification and diabetic neuropathy. Br Med J Clin Res Ed. 1982;284:928\u201330.","journal-title":"Br Med J Clin Res Ed"},{"key":"509_CR6","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.jacc.2007.12.058","volume":"51","author":"RJ Guzman","year":"2008","unstructured":"Guzman RJ, Brinkley DM, Schumacher PM, Donahue RMJ, Beavers H, Qin X. Tibial artery calcification as a marker of amputation risk in patients with peripheral arterial disease. J Am Coll Cardiol. 2008;51:1967\u201374.","journal-title":"J Am Coll Cardiol"},{"key":"509_CR7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/MNH.0b013e328362155b","volume":"22","author":"ZA Massy","year":"2013","unstructured":"Massy ZA, Dr\u00fceke TB. Vascular calcification. Curr Opin Nephrol Hypertens. 2013;22:405\u201312.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"509_CR8","volume-title":"Medial arterial calcification: an overlooked player in peripheral arterial disease","author":"CY Ho","year":"2016","unstructured":"Ho CY, Shanahan CM. Medial arterial calcification: an overlooked player in peripheral arterial disease. Biol: Arterioscler Thromb Vasc; 2016."},{"key":"509_CR9","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1161\/CIRCRESAHA.110.234088","volume":"108","author":"GP Fadini","year":"2011","unstructured":"Fadini GP, Albiero M, Menegazzo L, Boscaro E, Vigili de Kreutzenberg S, Agostini C, et al. Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes. Circ Res. 2011;108:1112\u201321.","journal-title":"Circ Res"},{"key":"509_CR10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1210\/en.2009-0833","volume":"151","author":"H Li","year":"2010","unstructured":"Li H, Jiang L-S, Dai L-Y. High glucose potentiates collagen synthesis and bone morphogenetic protein-2-induced early osteoblast gene expression in rat spinal ligament cells. Endocrinology. 2010;151:63\u201374.","journal-title":"Endocrinology"},{"key":"509_CR11","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1159\/000226225","volume":"46","author":"T Tanikawa","year":"2009","unstructured":"Tanikawa T, Okada Y, Tanikawa R, Tanaka Y. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE\/p38 MAPK. J Vasc Res. 2009;46:572\u201380.","journal-title":"J Vasc Res"},{"key":"509_CR12","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2147\/VHRM.S1905","volume":"4","author":"A Ribeiro-Oliveira","year":"2008","unstructured":"Ribeiro-Oliveira A, Nogueira AI, Pereira RM, Boas WWV, dos Santos RAS, e Silva ACS. The renin\u2013angiotensin system and diabetes: an update. Vasc Health Risk Manag. 2008;4:787\u2013803.","journal-title":"Vasc Health Risk Manag."},{"key":"509_CR13","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/ki.2013.271","volume":"85","author":"Y Fang","year":"2014","unstructured":"Fang Y, Ginsberg C, Sugatani T, Monier-Faugere M-C, Malluche H, Hruska KA. Early chronic kidney disease-mineral bone disorder stimulates vascular calcification. Kidney Int. 2014;85:142\u201350.","journal-title":"Kidney Int"},{"key":"509_CR14","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.jacc.2007.08.032","volume":"50","author":"DV Anand","year":"2007","unstructured":"Anand DV, Lim E, Darko D, Bassett P, Hopkins D, Lipkin D, et al. Determinants of progression of coronary artery calcification in type 2 diabetes role of glycemic control and inflammatory\/vascular calcification markers. J Am Coll Cardiol. 2007;50:2218\u201325.","journal-title":"J Am Coll Cardiol"},{"key":"509_CR15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2337\/dc14-0360","volume":"38","author":"AP Carson","year":"2015","unstructured":"Carson AP, Steffes MW, Carr JJ, Kim Y, Gross MD, Carnethon MR, et al. Hemoglobin A1c and the progression of coronary artery calcification among adults without diabetes. Diabetes Care. 2015;38:66\u201371.","journal-title":"Diabetes Care"},{"key":"509_CR16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.arcmed.2014.11.011","volume":"46","author":"C-H Jung","year":"2015","unstructured":"Jung C-H, Rhee E-J, Kim K-J, Kim B-Y, Park SE, Chang Y, et al. Relationship of glycated hemoglobin A1c, coronary artery calcification and insulin resistance in males without diabetes. Arch Med Res. 2015;46:71\u20137.","journal-title":"Arch Med Res"},{"key":"509_CR17","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1007\/s00125-002-0920-8","volume":"45","author":"E Ishimura","year":"2002","unstructured":"Ishimura E, Okuno S, Kitatani K, Kim M, Shoji T, Nakatani T, et al. Different risk factors for peripheral vascular calcification between diabetic and non-diabetic haemodialysis patients\u2013importance of glycaemic control. Diabetologia. 2002;45:1446\u20138.","journal-title":"Diabetologia"},{"key":"509_CR18","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1210\/en.2013-1002","volume":"154","author":"X Cao","year":"2013","unstructured":"Cao X, Li H, Tao H, Wu N, Yu L, Zhang D, et al. Metformin inhibits vascular calcification in female rat aortic smooth muscle cells via the AMPK-eNOS-NO pathway. Endocrinology. 2013;154:3680\u20139.","journal-title":"Endocrinology"},{"key":"509_CR19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.vph.2016.01.002","volume":"81","author":"X Zhang","year":"2016","unstructured":"Zhang X, Xiao J, Li R, Qin X, Wang F, Mao Y, et al. Metformin alleviates vascular calcification induced by vitamin D3 plus nicotine in rats via the AMPK pathway. Vasc Pharmacol. 2016;81:83\u201390.","journal-title":"Vasc Pharmacol."},{"key":"509_CR20","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/CIRCRESAHA.116.308301","volume":"119","author":"Z Cai","year":"2016","unstructured":"Cai Z, Ding Y, Zhang M, Lu Q, Wu S, Zhu H, et al. Ablation of adenosine monophosphate-activated protein kinase \u03b11 in vascular smooth muscle cells promotes diet-induced atherosclerotic calcification in vivo. Circ Res. 2016;119:422\u201333.","journal-title":"Circ Res"},{"key":"509_CR21","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1210\/jc.2014-1047","volume":"99","author":"O Bourron","year":"2014","unstructured":"Bourron O, Aubert CE, Liabeuf S, Cluzel P, Lajat-Kiss F, Dadon M, et al. Below-knee arterial calcification in type 2 diabetes: association with receptor activator of nuclear factor \u03baB ligand, osteoprotegerin, and neuropathy. J Clin Endocrinol Metab. 2014;99:4250\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"509_CR22","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1373\/clinchem.2006.077180","volume":"53","author":"AS Levey","year":"2007","unstructured":"Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, et al. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53:766\u201372.","journal-title":"Clin Chem"},{"key":"509_CR23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","volume":"15","author":"AS Agatston","year":"1990","unstructured":"Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827\u201332.","journal-title":"J Am Coll Cardiol"},{"key":"509_CR24","doi-asserted-by":"crossref","first-page":"e0137596","DOI":"10.1371\/journal.pone.0137596","volume":"10","author":"KK Clemens","year":"2015","unstructured":"Clemens KK, Shariff S, Liu K, Hramiak I, Mahon JL, McArthur E, et al. Trends in antihyperglycemic medication prescriptions and hypoglycemia in older adults: 2002\u20132013. PLoS ONE. 2015;10:e0137596.","journal-title":"PLoS ONE"},{"key":"509_CR25","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/dc14-2441","volume":"38","author":"SE Inzucchi","year":"2015","unstructured":"Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the american diabetes association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38:140\u20139.","journal-title":"Diabetes Care"},{"key":"509_CR26","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577\u201389.","journal-title":"N Engl J Med"},{"key":"509_CR27","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854\u201365.","journal-title":"Lancet"},{"key":"509_CR28","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1007\/s00125-004-1547-8","volume":"47","author":"N Katakami","year":"2004","unstructured":"Katakami N, Yamasaki Y, Hayaishi-Okano R, Ohtoshi K, Kaneto H, Matsuhisa M, et al. Metformin or gliclazide, rather than glibenclamide, attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes. Diabetologia. 2004;47:1906\u201313.","journal-title":"Diabetologia"},{"key":"509_CR29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.diabres.2003.11.007","volume":"64","author":"K Matsumoto","year":"2004","unstructured":"Matsumoto K, Sera Y, Abe Y, Tominaga T, Yeki Y, Miyake S. Metformin attenuates progression of carotid arterial wall thickness in patients with type 2 diabetes. Diabetes Res Clin Pract. 2004;64:225\u20138.","journal-title":"Diabetes Res Clin Pract"},{"key":"509_CR30","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1001\/archinternmed.2010.409","volume":"170","author":"R Roussel","year":"2010","unstructured":"Roussel R, Travert F, Pasquet B, Wilson PWF, Smith SC, Goto S, et al. Metformin use and mortality among patients with diabetes and atherothrombosis. Arch Intern Med. 2010;170:1892\u20139.","journal-title":"Arch Intern Med"},{"key":"509_CR31","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/00005344-198409000-00027","volume":"6","author":"CR Sirtori","year":"1984","unstructured":"Sirtori CR, Franceschini G, Gianfranceschi G, Sirtori M, Montanari G, Bosisio E, et al. Metformin improves peripheral vascular flow in nonhyperlipidemic patients with arterial disease. J Cardiovasc Pharmacol. 1984;6:914\u201323.","journal-title":"J Cardiovasc Pharmacol"},{"key":"509_CR32","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.2337\/dc15-0658","volume":"38","author":"T Xu","year":"2015","unstructured":"Xu T, Brandmaier S, Messias AC, Herder C, Draisma HHM, Demirkan A, et al. Effects of metformin on metabolite profiles and LDL cholesterol in patients with type 2 diabetes. Diabetes Care. 2015;38:1858\u201367.","journal-title":"Diabetes Care"},{"key":"509_CR33","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.atherosclerosis.2013.10.025","volume":"232","author":"B Batchuluun","year":"2014","unstructured":"Batchuluun B, Inoguchi T, Sonoda N, Sasaki S, Inoue T, Fujimura Y, et al. Metformin and liraglutide ameliorate high glucose-induced oxidative stress via inhibition of PKC-NAD(P)H oxidase pathway in human aortic endothelial cells. Atherosclerosis. 2014;232:156\u201364.","journal-title":"Atherosclerosis."},{"key":"509_CR34","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2337\/db07-1098","volume":"57","author":"JW Calvert","year":"2008","unstructured":"Calvert JW, Gundewar S, Jha S, Greer JJM, Bestermann WH, Tian R, et al. Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling. Diabetes. 2008;57:696\u2013705.","journal-title":"Diabetes"},{"key":"509_CR35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12933-016-0408-3","volume":"15","author":"J-W Yu","year":"2016","unstructured":"Yu J-W, Deng Y-P, Han X, Ren G-F, Cai J, Jiang G-J. Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK\/eNOS pathway in diabetic mice. Cardiovasc Diabetol. 2016;15:88.","journal-title":"Cardiovasc Diabetol."},{"key":"509_CR36","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12933-016-0413-6","volume":"15","author":"FW Ahmed","year":"2016","unstructured":"Ahmed FW, Rider R, Glanville M, Narayanan K, Razvi S, Weaver JU. Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study. Cardiovasc Diabetol. 2016;15:116.","journal-title":"Cardiovasc Diabetol"},{"key":"509_CR37","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1124\/jpet.115.226894","volume":"356","author":"G Arunachalam","year":"2016","unstructured":"Arunachalam G, Lakshmanan AP, Samuel SM, Triggle CR, Ding H. Molecular interplay between microRNA-34a and Sirtuin1 in hyperglycemia-mediated impaired angiogenesis in endothelial cells: effects of metformin. J Pharmacol Exp Ther. 2016;356:314\u201323.","journal-title":"J Pharmacol Exp Ther"},{"key":"509_CR38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12933-016-0344-2","volume":"15","author":"S Bakhashab","year":"2016","unstructured":"Bakhashab S, Ahmed FW, Schulten H-J, Bashir A, Karim S, Al-Malki AL, et al. Metformin improves the angiogenic potential of human CD34+ cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction. Cardiovasc Diabetol. 2016;15:27.","journal-title":"Cardiovasc Diabetol."},{"key":"509_CR39","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00125-013-3087-6","volume":"57","author":"GP Fadini","year":"2014","unstructured":"Fadini GP. A reappraisal of the role of circulating (progenitor) cells in the pathobiology of diabetic complications. Diabetologia. 2014;57:4\u201315.","journal-title":"Diabetologia"},{"key":"509_CR40","doi-asserted-by":"crossref","first-page":"i1450","DOI":"10.1136\/bmj.i1450","volume":"352","author":"J Hippisley-Cox","year":"2016","unstructured":"Hippisley-Cox J, Coupland C. Diabetes treatments and risk of amputation, blindness, severe kidney failure, hyperglycaemia, and hypoglycaemia: open cohort study in primary care. BMJ. 2016;352:i1450.","journal-title":"BMJ"},{"key":"509_CR41","doi-asserted-by":"crossref","first-page":"15319","DOI":"10.1074\/jbc.M800021200","volume":"283","author":"CH Byon","year":"2008","unstructured":"Byon CH, Javed A, Dai Q, Kappes JC, Clemens TL, Darley-Usmar VM, et al. Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem. 2008;283:15319\u201327.","journal-title":"J Biol Chem"},{"key":"509_CR42","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijcard.2008.04.010","volume":"134","author":"N-L Huang","year":"2009","unstructured":"Huang N-L, Chiang S-H, Hsueh C-H, Liang Y-J, Chen Y-J, Lai L-P. Metformin inhibits TNF-\u03b1-induced I\u03baB kinase phosphorylation, I\u03baB-\u03b1 degradation and IL-6 production in endothelial cells through PI3\u00a0K-dependent AMPK phosphorylation. Int J Cardiol. 2009;134:169\u201375.","journal-title":"Int J Cardiol"},{"key":"509_CR43","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000197871","volume":"71","author":"T Tsilchorozidou","year":"2009","unstructured":"Tsilchorozidou T, Mohamed-Ali V, Conway GS. Determinants of interleukin-6 and C-reactive protein vary in polycystic ovary syndrome, as do effects of short- and long-term metformin therapy. Horm Res. 2009;71:148\u201354.","journal-title":"Horm Res"},{"key":"509_CR44","doi-asserted-by":"crossref","first-page":"c380","DOI":"10.1159\/000323739","volume":"118","author":"HJ Nye","year":"2011","unstructured":"Nye HJ, Herrington WG. Metformin: the safest hypoglycaemic agent in chronic kidney disease? Nephron Clin Pract. 2011;118:c380\u20133.","journal-title":"Nephron Clin Pract."},{"key":"509_CR45","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.2337\/dc10-2361","volume":"34","author":"KJ Lipska","year":"2011","unstructured":"Lipska KJ, Bailey CJ, Inzucchi SE. Use of metformin in the setting of mild-to-moderate renal insufficiency. Diabetes Care. 2011;34:1431\u20137.","journal-title":"Diabetes Care"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-017-0509-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T06:36:22Z","timestamp":1498372582000},"score":1,"resource":{"primary":{"URL":"http:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-017-0509-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,15]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["509"],"URL":"https:\/\/doi.org\/10.1186\/s12933-017-0509-7","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,15]]},"article-number":"24"}}